DNA insider buying and SEC filings, explained
Ginkgo Bioworks Holdings, Inc. · CIK 1830214
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$4.1M
Planned sales (10b5-1)
$36K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 19, 2026 | Sale | Steven P. Coen (CFO) sold 766 shares at $10.14 ($8K). Holdings down 2% to 50,168 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 21, 2026, 4:07 PM ET |
| Oct 19, 2026 | Sale | Barry Canton (10% owner) sold 41,172 shares directly and indirectly (by spouse) at $10.14 ($418K). Direct holdings down 5% to 356,329 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 21, 2026, 4:06 PM ET |
| Oct 19, 2026 | Sale | Reshma P. Shetty (President / COO and Director) sold 41,172 shares directly and indirectly (by spouse) at $10.14 ($418K). Direct holdings down 5% to 453,951 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 21, 2026, 4:06 PM ET |
| Oct 19, 2026 | Sale | Jason R Kelly (CEO and Director) sold 45,682 shares at $10.14 ($463K). Holdings down 26% to 129,065 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 21, 2026, 4:05 PM ET |
| Oct 5, 2026 | Planned (10b5-1) | Steven P. Coen (CFO) sold 2,403 shares at $15.00 ($36K), marked as a 10b5-1 plan trade. Holdings down 5% to 49,448 shares. | SEC filing Filed Oct 7, 2026, 5:00 PM ET |
| Sep 15, 2026 | Sale | Christian O. Henry (Director) sold 5,000 shares at about $7.08 ($35K). Holdings down 21% to 19,310 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 16, 2026 |
| Aug 24, 2026 | Sale | Steven P. Coen (CFO) sold 330 shares at $6.98 ($2K). Holdings down 1% to 51,851 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 25, 2026 |
| Jul 17, 2026 | Sale | Steven P. Coen (CFO) sold 752 shares at $7.90 ($6K). Holdings down 1% to 51,438 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 20, 2026 |
| May 22, 2026 | Sale | Steven P. Coen (CFO) sold 307 shares at $8.33 ($3K). Holdings down 1% to 50,704 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 26, 2026 |
| Apr 17, 2026 | Sale | Steven P. Coen (CFO) sold 324 shares at $7.95 ($3K). Holdings down 1% to 50,268 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 20, 2026 |
| Apr 13, 2026 | Sale | Steven P. Coen (CFO) sold 33,171 shares at $6.41 ($213K). Holdings down 40% to 49,849 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 14, 2026 |
| Apr 10, 2026 | Sale | Barry Canton (10% owner) sold 124,727 shares indirectly (by spouse) at $6.43 ($802K). Holdings by spouse down 22% to 436,422 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 13, 2026 |
| Apr 10, 2026 | Sale | Reshma P. Shetty (President / COO and Director) sold 124,727 shares at $6.43 ($802K). Holdings down 22% to 436,422 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 13, 2026 |
| Apr 9, 2026 | Sale | Reshma P. Shetty (President / COO and Director) sold 13,116 shares indirectly (by spouse) at $6.40 ($84K). Holdings by spouse down 4% to 338,568 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 10, 2026 |
| Apr 9, 2026 | Sale | Barry Canton (10% owner) sold 13,116 shares at $6.40 ($84K). Holdings down 4% to 338,568 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 10, 2026 |
| Apr 9, 2026 | Sale | Jason R Kelly (CEO and Director) sold 109,767 shares at $6.40 ($703K). Holdings down 26% to 316,483 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 10, 2026 |
| Mar 16, 2026 | Sale | Steven P. Coen (CFO) sold 708 shares at $6.74 ($5K). Holdings down 7% to 9,099 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 18, 2026 |
| Jan 20, 2026 | Sale | Steven P. Coen (CFO) sold 972 shares at $8.92 ($9K). Holdings down 10% to 8,321 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 22, 2026 |
| Dec 15, 2025 | Sale | Steven P. Coen (CFO) sold 736 shares at $8.89 ($7K). Holdings down 9% to 7,488 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 16, 2025 |
27 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow DNA in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.